Satellite Bio

About:

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Website: https://www.satellite.bio/

Top Investors: Alumni Ventures, Lightspeed Venture Partners, Catalio Capital Management, Polaris Partners, Section 32

Description:

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.

Total Funding Amount:

$101M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Arnav Chhabra, Christopher Chen, Sangeeta Bhatia

Number of Employees:

11-50

Last Funding Date:

2022-03-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai